TY - JOUR
T1 - Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients
AU - Garza, Juan
AU - Anderson, Jane Margret
AU - Scherber, Robyn M.
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2020/4
Y1 - 2020/4
N2 - Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes are rare types of chronic myeloid hematologic neoplasms. Patients with overlap syndrome have similar clinical features, mutations, and disease course, to other chronic myeloid malignancies. Limited data also suggests that overlap syndromes patients experience long standing and at times poorly controlled symptoms that may be underrecognized. In this article, we discuss the etiologies of symptoms in patients with overlap syndromes and currently available symptom burden assessment tools. Overall, symptom burden is an important consideration in patients with overlap syndrome, and efforts are ongoing to further investigate symptom burden and quality of life in this population.
AB - Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes are rare types of chronic myeloid hematologic neoplasms. Patients with overlap syndrome have similar clinical features, mutations, and disease course, to other chronic myeloid malignancies. Limited data also suggests that overlap syndromes patients experience long standing and at times poorly controlled symptoms that may be underrecognized. In this article, we discuss the etiologies of symptoms in patients with overlap syndromes and currently available symptom burden assessment tools. Overall, symptom burden is an important consideration in patients with overlap syndrome, and efforts are ongoing to further investigate symptom burden and quality of life in this population.
KW - Atypical chronic myelogenous leukemia
KW - Chronic myelomonocytic leukemia
KW - Chronic neutrophilic leukemia
KW - Juvenile myelomonocytic leukemia
KW - Quality of life
KW - Symptom burden
UR - http://www.scopus.com/inward/record.url?scp=85076829392&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076829392&partnerID=8YFLogxK
U2 - 10.1016/j.hoc.2019.11.001
DO - 10.1016/j.hoc.2019.11.001
M3 - Review article
C2 - 32089224
AN - SCOPUS:85076829392
SN - 0889-8588
VL - 34
SP - 475
EP - 489
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 2
ER -